Reflected Light Glare Minimization for Athletic Contest Participants While Providing a Non Verbal Communication
    4.
    发明申请
    Reflected Light Glare Minimization for Athletic Contest Participants While Providing a Non Verbal Communication 有权
    提供非言语交流的竞技比赛参赛者的反射光眩光最小化

    公开(公告)号:US20070277925A1

    公开(公告)日:2007-12-06

    申请号:US11779584

    申请日:2007-07-18

    IPC分类号: B44C1/17

    摘要: A method and product for reducing reflected light glare into a human's eyes from the human's cheeks while simultaneously providing a non-verbal communication to others is provided, especially for use by participants in athletic contests. Underneath the human's eyes on the cheeks at a reflective location on the cheeks at which incident direct or indirect light is likely to be reflected into a human's eyes a non-toxic, non-reflective colored and finished material in the form of a predefined clearly demarcated geometric shape is applied. Within a week after the application (typically within less than a few hours after the athletic contest is over) the non-reflective material is removed. The non-reflective material may comprise eye black, applied using a stencil, or it may comprise a temporary tattoo or decal, applied in the conventional manner. The shape preferably is a sports apparel or equipment manufacturer's or distributor's logo and/or letters, or a team name, mascot or logo. The material is preferably black or dark colored, and any non-black or non-dark colored portions providing demarcation between elements of the shape comprises a dull or matte color having a wavelength of greater than about 650 nm and less than about 470 nm.

    摘要翻译: 提供了一种减少反射光的方法和产品,从人的脸颊眩光到人的眼睛,同时提供与他人的非言语交流,特别是参加运动竞赛的使用者。 人脸的眼睛在脸颊上的反光位置上,事件直接或间接的光线可能会被反射到人眼中,这是一种无毒,无反光的彩色和成品材料,以预先明确划分的形式 应用几何形状。 在申请之后的一个星期内(通常在运动竞赛结束后不到几个小时内),不反光材料被去除。 非反射材料可以包括使用模版施加的眼睛黑色,或者它可以包括以常规方式施加的临时纹身或贴花。 该形状优选地是运动服装或设备制造商或经销商的标识和/或信件,或团队名称,吉祥物或标志。 该材料优选为黑色或深色,并且提供形状的元件之间的划分的任何非黑色或非深色部分包括具有大于约650nm且小于约470nm的波长的钝的或无光泽的颜色。

    Formulations for treating or preventing mucositis
    5.
    发明申请
    Formulations for treating or preventing mucositis 审中-公开
    治疗或预防粘膜炎的制剂

    公开(公告)号:US20060084633A1

    公开(公告)日:2006-04-20

    申请号:US11230397

    申请日:2005-09-20

    IPC分类号: A61K31/65 A61L9/04 A61K9/127

    摘要: Mucositis is treated and/or prevented by administrating to a patient a formulation comprising a tetracycline that is poorly absorbed from the gastro-intestinal tract. The tetracycline may be in the form of a pharmaceutically acceptable salt or a base. The formulations may optionally also contain an antifungal agent to prevent fungal overgrowth due to reduction in the normal oral flora by the tetracycline. Such compositions have the advantage of treating the entire gastrointestinal tract since the active ingredient is not removed from the tract via absorption. Further, such compositions minimize systemic exposure and accompanying side effects.

    摘要翻译: 通过向患者施用包含从胃肠道吸收不良的四环素的制剂来治疗和/或预防粘膜炎。 四环素可以是药学上可接受的盐或碱的形式。 制剂还可任选地含有抗真菌剂,以防止由四环素引起的正常口腔菌群减少引起的真菌过度生长。 这样的组合物具有治疗整个胃肠道的优点,因为活性成分不通过吸收从管道中除去。 此外,这样的组合物使全身暴露和伴随的副作用最小化。